These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26712271)

  • 1. Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients.
    Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):80-3. PubMed ID: 26712271
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.
    Christodoulou M; Aspray TJ; Piec I; Fraser WD; Schoenmakers I;
    Age Ageing; 2024 May; 53(5):. PubMed ID: 38770543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine and progression of chronic kidney disease: a one-year follow-up study.
    Eiselt J; Rajdl D; Racek J; Vostrý M; Rulcová K; Wirth J
    Kidney Blood Press Res; 2014; 39(1):50-7. PubMed ID: 24923294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
    Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
    J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.
    Tripepi G; Kollerits B; Leonardis D; Yilmaz MI; Postorino M; Fliser D; Mallamaci F; Kronenberg F; Zoccali C
    J Am Soc Nephrol; 2015 Apr; 26(4):935-44. PubMed ID: 25150156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry.
    Pecchini P; Malberti F; Mieth M; Quinn R; Tripepi G; Mallamaci F; Maas R; Zoccali C; Ravani P
    J Nephrol; 2012; 25(6):1016-22. PubMed ID: 22322824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.
    Ghanavatian S; Diep LM; Bárány P; Heimbürger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
    Angiology; 2014 May; 65(5):443-9. PubMed ID: 23567479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethylarginines as risk markers of atherosclerosis and chronic kidney disease in children with nephrotic syndrome.
    Hyla-Klekot L; Bryniarski P; Pulcer B; Ziora K; Paradysz A
    Adv Clin Exp Med; 2015; 24(2):307-14. PubMed ID: 25931365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease.
    Asmarawati TP; Widodo ; Thaha M; Aditiawardana ; Mardiana N; Ardhany AR; Tjempakasari A; Santoso D; Pranawa ; Irwanadi C
    Acta Med Indones; 2016 Jan; 48(1):28-34. PubMed ID: 27241541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
    Aydemir O; Ozcan B; Yucel H; Bas AY; Demirel N
    J Matern Fetal Neonatal Med; 2015 May; 28(8):977-82. PubMed ID: 24983667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23 in Acute and Chronic Illness.
    Schnedl C; Fahrleitner-Pammer A; Pietschmann P; Amrein K
    Dis Markers; 2015; 2015():358086. PubMed ID: 26491212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Coombes JS
    Clin Nephrol; 2014 Feb; 81(2):75-85. PubMed ID: 24321183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Am J Med Sci; 2014 May; 347(5):370-6. PubMed ID: 24051956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.
    Zoccali C; Maas R; Cutrupi S; Pizzini P; Finocchiaro P; Cambareri F; Panuccio V; Martorano C; Schulze F; Enia G; Tripepi G; Boger R
    Nephrol Dial Transplant; 2007 Mar; 22(3):801-6. PubMed ID: 17166859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Fibroblast Growth Factor 23 Assays.
    Jialal I
    J Appl Lab Med; 2020 Jul; 5(4):819-821. PubMed ID: 32603434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.